Novo plans to launch oral Wegovy, or “Wegovy-in-a-pill,” in the U.S.
Novavax Inc. shares fell 20% after US regulators placed a hold on the development of its experimental flu vaccines following a severe adverse event that occurred in a single clinical trial participant